Chaperone-amyloid interactions
伴侣-淀粉样蛋白相互作用
基本信息
- 批准号:8553390
- 负责人:
- 金额:$ 7.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffectAmyloidBindingBiochemicalC-terminalCellsDiseaseGeneticGlutamineGoalsIn VitroKineticsMediatingMethodsMolecularMolecular ChaperonesMutationN-terminalPhenotypePrionsPropertyProtein Structure InitiativeProteinsStructureToxic effectVariantWorkYeastsamyloid formationfallshuman Huntingtin proteinin vivointerestmutantoverexpressionpolyglutaminepolyprolinesup35
项目摘要
Expressing proteins with high propensity to from amyloid, such as disease-associated huntingtin (Htt) fragments with 103 glutamines (HttQ103), is toxic in yeast containing either the PIN+ prion, which is the amyloid form of Rnq1, or PSI+ prion, which is the amyloid form of Sup35. In an effort to understand this toxicity we examined in detail the effects of expressing various Htt fragments in cells propagating different prion variants. HttQP103, which has a polyproline region at the C-terminal end of the polyQ repeat region, is significantly more toxic in yeast with PSI+ than PIN+. This toxicity observed in cells with a strong PSI+ variant was not seen in a weak PSI+ variant, which has more soluble Sup35 than the strong variant. Additionally, expression of Sup35p MC region, which remains soluble in PSI+ yeast because it lacks the N-terminal prion domain, almost completely rescued HttQP103 toxicity. Overexpressing the essential Sup45p, which binds to and functions with Sup35p, did not restore viability. Therefore, the toxicity of HttQP103 in yeast containing the PSI+ prion is primarily due to sequestration of the essential Sup35 protein.
We are also continuing studies of how alterations in primary structure of prion proteins can affect chaperone interactions. We have been isolating mutants of prion proteins that fall into two major classes, those that interfere with propagation of prions formed of wild type proteins and those that don't. Both types of mutants contain subclasses that, in the absence of wild type protein, either form prions with weakened phenotypes or are unable to form prions. We are using genetic and biochemical methods to determine if the observed effects on prion phenotype are due to differences in how the prion proteins self-associate or interact with various chaperones. Our preliminary work suggests that the prion protein mutations can influence the propagation of amyloid directly, or the interaction of chaperones that in turn affect how efficiently the prions propagate.
表达具有淀粉样蛋白高倾向的蛋白质,例如疾病相关的亨廷顿蛋白(HTT)片段,具有103个谷氨酰胺(HTTQ103),在酵母中有毒,其中含有PIN+ PRION,含有PIN+ PRION,这是RNQ1或PSI+ Prion+ PSI+ Prion的淀粉样蛋白形式,或者是PSI+ Prion的淀粉样蛋白,这是Sup3的淀粉样蛋白。为了理解这种毒性,我们详细研究了表达各种HTT片段在传播不同prion变体的细胞中的影响。 HTTQP103在PolyQ重复区域的C末端具有多生区域,在PSI+的酵母中毒性明显高于PIN+。在弱的PSI+变体中未看到这种毒性在具有强PSI+变体的细胞中观察到的毒性,该变体的可溶性sup35比强的变体更可溶。此外,Sup35p MC区域的表达(由于缺乏N末端prion域缺乏)而溶于PSI+酵母菌中,几乎完全挽救了HTTQP103的毒性。与SUP35P结合并函数的Essential Sup45p过表达并未恢复生存能力。因此,HTTQP103在包含PSI+ Prion的酵母中的毒性主要是由于必需SUP35蛋白的隔离。
我们还在继续研究prion蛋白主要结构的变化如何影响伴侣的相互作用。我们一直在隔离落入两个主要类别的prion蛋白的突变体,这些类别会干扰由野生型蛋白质和不繁殖的prions的传播。两种类型的突变体都包含子类,在没有野生型蛋白质的情况下,要么形成弱的表型prions,要么无法形成王室。我们使用遗传和生化方法来确定观察到的对prion表型的影响是否是由于prion蛋白如何自我缔合或与各种伴侣相互作用的差异。我们的初步工作表明,prion蛋白突变可以直接影响淀粉样蛋白的传播,或者会影响伴侣的相互作用,而伴侣的相互作用反过来影响王室的传播效率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Masison其他文献
Daniel Masison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Masison', 18)}}的其他基金
相似国自然基金
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
b-淀粉样蛋白与人体血清白蛋白相互作用机制的分子模拟研究
- 批准号:11804218
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
汉族人群ABCA7功能缺失突变与阿尔茨海默病的关联及其致病机制研究
- 批准号:81701253
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
抗APP铜离子结合域自身抗体在阿尔茨海默病发生发展中的作用和机制研究
- 批准号:81701046
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
sAPPα-BACE1结合位点模拟肽在阿尔茨海默病防治中的作用和机制研究
- 批准号:81671277
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 7.45万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 7.45万 - 项目类别:
Immunomodulatory and behavioral effects of CAR T regulatory cell therapy for Alzheimer's Disease”.
CAR T 调节细胞疗法对阿尔茨海默病的免疫调节和行为影响。
- 批准号:
10633721 - 财政年份:2023
- 资助金额:
$ 7.45万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 7.45万 - 项目类别:
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
揭示 MS4A 基因家族在阿尔茨海默病中的作用
- 批准号:
10751885 - 财政年份:2023
- 资助金额:
$ 7.45万 - 项目类别: